Skip to main content
Veterinary Medicines

Kabergovet 50 microgram/ml oral solution for dogs and cats.

Authorised
  • Cabergoline

Product identification

Medicine name:
Kabergovet 50 microgram/ml oral solution for dogs and cats.
Kabergovet 50 microgramas/ml solução oral para cães e gatos
Active substance:
  • Cabergoline
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cabergoline
    50.00
    microgram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral liquid
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG02CB03
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Available in:
  • Portugal
Package description:
  • Cardboard box with 1 x amber PET bottle of 15 ml capacity (containing 15 ml) closed by HDPE screw cap with LDPE plug and safety seal supplied with 3 ml PP oral syringe with HDPE plunger
  • Cardboard box with 1 x amber PET bottle of 15 ml capacity (containing 7 ml) closed by HDPE screw cap with LDPE plug and safety seal supplied with 3 ml PP oral syringe with HDPE plunger

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Vet-Agro Multi-Trade Company Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Multi-Trade Company "Vet-Agro" Sp. z o.o.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 1385/01/20DFVPT
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0312/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Lithuania
  • Poland
  • Portugal
  • Spain

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 11/11/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."